Who is sponsoring NCT02942485?

NCT02942485 is sponsored by Helsinki University Central Hospital.

What condition does NCT02942485 study?

NCT02942485 studies GIARDIASIS.

What drugs are being tested in NCT02942485?

Interventions: Metronidazole, Tinidazole.

What is the status of NCT02942485?

NCT02942485 is currently TERMINATED.

Last reviewed 2020-11-18 · How we verify

Treatment of Giardia Lamblia Infections in Children

NCT02942485 PHASE4 TERMINATED Results posted

This study investigates the efficacy and safety of rectally administered metronidazole for pediatric Giardia lamblia infection, as well as the acceptance of this treatment regimen by patients/caregivers. The investigators hypothesize that rectal metronidazole is non-inferior to single-dose of oral tinidazole and will cure at least 72% of patients, a well as will be tolerated as good as tinidazole.

Details

Lead sponsor	Helsinki University Central Hospital
Phase	PHASE4
Status	TERMINATED
Enrolment	8
Start date	Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

GIARDIASIS

Interventions

Metronidazole
Tinidazole

Countries

Finland